Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRIANT-TE study of lithium versus rivastigmine for HIV-associated neurocognitive impairment
2010-024510-57Phase 4Completed
- Sponsor
- Fight AIDS and Infectious Diseases Foundation
- Start
- Jan 2011
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in HIV encephalopathy (HAND) and AIDS Dementia Complex (HAD) comparing Lithium carbonate arm with Rivastigmine arm (2 arms). Started Jan 2011; status: completed.
02
Drugs
lithium carbonaterivastigmine
03
Conditions
HIV encephalopathy (HAND)AIDS Dementia Complex (HAD)
Beyond the preview
Go deeper on 2010-024510-57.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-024510-57.